www.fdanews.com/articles/84895-atrium-biotechnologies-q4-profit-jumps-78-to-4m
ATRIUM BIOTECHNOLOGIES Q4 PROFIT JUMPS 78% TO $4M
February 28, 2006
Atrium Biotechnologies Inc. (TSX: ATB.SV) reported higher profits in the fourth quarter as the maker of specialty chemicals for the pharmaceutical, cosmetics and nutrition industries generated sharply higher revenues. The Quebec-based company said Tuesday its net earnings for the three months ended Dec. 31 rose 78 per cent to US$4.0 million or 14 cents a share, compared with US$2.3 million or 10 cents a share for the same period in 2004.